Dr. Reddy’s Stock Hits A Record High As Analysts Hike Target Prices After Q1
Pills move through a sorting machine at a pharmaceutical plant. (Photographer: Sara Hylton/Bloomberg)

Dr. Reddy’s Stock Hits A Record High As Analysts Hike Target Prices After Q1

Shares of Dr. Reddy’s Laboratories Ltd. touched an all-time high as analysts raised their target prices after the drugmaker beat estimates in a quarter marred by the coronavirus pandemic.A healthy ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.